| Product NDC: | 0008-4117 |
| Proprietary Name: | Trecator |
| Non Proprietary Name: | ethionamide |
| Active Ingredient(s): | 250 mg/1 & nbsp; ethionamide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0008-4117 |
| Labeler Name: | Wyeth Pharmaceuticals Company, a subsidiary of Pfizer Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA013026 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20041108 |
| Package NDC: | 0008-4117-01 |
| Package Description: | 100 TABLET, FILM COATED in 1 BOTTLE (0008-4117-01) |
| NDC Code | 0008-4117-01 |
| Proprietary Name | Trecator |
| Package Description | 100 TABLET, FILM COATED in 1 BOTTLE (0008-4117-01) |
| Product NDC | 0008-4117 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ethionamide |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20041108 |
| Marketing Category Name | NDA |
| Labeler Name | Wyeth Pharmaceuticals Company, a subsidiary of Pfizer Inc. |
| Substance Name | ETHIONAMIDE |
| Strength Number | 250 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Antimycobacterial [EPC] |